Fri, Sep 19, 2014, 2:47 AM EDT - U.S. Markets open in 6 hrs 43 mins


% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • johngunn51 johngunn51 Apr 12, 2013 11:39 AM Flag

    Peripheral neuropathy

    Look, the 59 people are very ill, God bless them, and the platinum drugs cause peripheral neuropathy by themselves. 901 works and it works at a substantially lower dose than 90mg per sq.ltr blood. These guys are very smart. If they can get a therapeutic dose in a tough setting, they will figure it out. No one in the analyst world expects 901 to succeed, 901 failure is already priced in at 17.50. If the analysts were really top notch people, they would be on the other side of the podium... This company is just at the beginning of a growth curve. If you can buy it and bank it on a crazy dip, you're smart to do so.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
11.34+0.04(+0.35%)Sep 18 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Oracle Corporation
NYSEThu, Sep 18, 2014 4:04 PM EDT
Concur Technologies, Inc.
NasdaqGSThu, Sep 18, 2014 4:00 PM EDT
Rite Aid Corporation
NYSEThu, Sep 18, 2014 4:02 PM EDT